Hancom Lifecare Inc.

As of June 30, 2026, Hancom Lifecare Inc. carries a market capitalization of 48.40B, placing it among publicly traded companies globally. Its enterprise value stands at 9.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Hancom Lifecare Inc.'s next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, Hancom Lifecare Inc. has 27.67M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.41, and the price-to-book ratio stands at 0.37.

As of June 30, 2026, Hancom Lifecare Inc. trades at an EV/EBITDA multiple of 1.13 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.08 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 2.53 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 9.28B versus a market cap of 48.40B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Hancom Lifecare Inc. maintains a current ratio of 1.95, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.28, indicating conservative leverage, while an interest coverage ratio of 545.56 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Hancom Lifecare Inc. posted a negative return on equity (ROE) of -0.31, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.21, reflecting losses generated across the asset base. The company generates approximately 552.20M in revenue per employee across its workforce of 216.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.08 indicates how many times Hancom Lifecare Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Hancom Lifecare Inc. recorded 169.67M in income tax expense. The company reported a pretax loss of -150.07M and -406.36M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Hancom Lifecare Inc.'s stock has declined approximately 26.85% over the past 52 weeks. The 50-day moving average sits at 1,961.54, while the 200-day moving average is 2,260.96.

Over the twelve months ended June 30, 2026, Hancom Lifecare Inc. generated 119.41B in revenue and converted that into -406.36M in net income, yielding earnings per share of -11.56. EBITDA reached 8.24B, while operating income came in at 3.67B.

As of June 30, 2026, Hancom Lifecare Inc. holds 40.19B in cash and equivalents against 373.35M in total debt, resulting in a net debt position of -39.91B. Total book value stands at 131.60B, with working capital of 54.56B providing operational flexibility.

Hancom Lifecare Inc. produced 21.55B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.64B in capital expenditures, free cash flow totaled 14.92B - equivalent to 539.11 per share.

Over the twelve months ended June 30, 2026, Hancom Lifecare Inc. posted a gross margin of 22.38, reflecting its pricing power and cost economics. The operating margin of 3.07 and net profit margin of -0.34 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 30.82, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.21, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Hancom Lifecare Inc. shareholders.

As of June 30, 2026, Hancom Lifecare Inc. has an Altman Z-Score of 2.64, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.